Gewas%D9%88%D8%B1%D9%85%E0%A6%A8%E0%A6%BF%E0%A6%93%E0%A6%AA%E0%A7%8D%E0%A6%B2%E0%A6%BE%E0%A6%9C%E0%A6%AENeopl%C3%A0siaTiwmorNeoplasi%CE%9D%CE%B5%CF%8C%CF%80%CE%BB%CE%B1%CF%83%CE%BC%CE%B1NeoplasmNeoplasiaKasvajaNeoplasia%D9%86%D8%A6%D9%88%D9%BE%D9%84%D8%A7%D8%B3%D9%85N%C3%A9oplasieSceachaillNeoplasia%D7%A0%D7%90%D7%95%D7%A4%D7%9C%D7%96%D7%99%D7%94%E0%A4%AB%E0%A5%81%E0%A4%B2%E0%A4%BE%E0%A4%B5NeoplasiaNeoplasmaNeoplasia%E0%B2%97%E0%B2%82%E0%B2%A4%E0%B2%BF%EC%8B%A0%EC%83%9D%EB%AC%BCNeoplasmaNeoplazmaNeoplasmaNeoplasieNeoplasiNeoplasiNowotw%C3%B3rNeoplasmaNeoplasmNeoplazma%D0%9D%D0%B5%D0%BE%D0%BF%D0%BB%D0%B0%D0%B7%D0%BC%D0%B0Neoplasi%E0%AE%95%E0%AE%9F%E0%AF%8D%E0%AE%9F%E0%AE%BF_(%E0%AE%89%E0%AE%AF%E0%AE%BF%E0%AE%B0%E0%AE%BF%E0%AE%AF%E0%AE%B2%E0%AF%8D)%E0%B9%80%E0%B8%99%E0%B8%B7%E0%B9%89%E0%B8%AD%E0%B8%87%E0%B8%AD%E0%B8%81%D9%86%D9%8F%D9%81%D9%91%D8%A7%D8%AEKh%E1%BB%91i_uQ1216998%E8%B4%85%E7%94%9F%E7%89%A9
about
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer TreatmentA Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing MalignanciesA Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate CancerVaccine and Chemotherapy for Previously Untreated Metastatic Breast CancerTumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or MediastinumPilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasTumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor RemovalImmunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic CancerAdjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary MetastasectomyA Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial CancerA Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid TumorsChemoimmunotherapy and Radiation in Pancreatic CancerαDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface MalignanciesCombine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical ResectionDinutuximab in Combination With Sargramostim in Treating Patients With Recurrent OsteosarcomaAn Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV MelanomaA Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell CancerAZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerOlaparib and Radium Ra 223 Dichloride in Treating Men With Metastatic Castration-Resistant Prostate Cancer That Has Spread to the BoneA Phase 1 Clinical Study of AZD4635 and Durvalumab in Patients With Advanced Solid Malignancies18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After InterventionsSafety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced MalignanciesNivolumab and Ipilimumab in Treating Patients With Rare TumorsPersonalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced MalignanciesPhase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, ALT-803 and Epacadostat (QuEST1)Evaluation of Factors in Human Brain TumorsThe Effects of Upper Airway and Digestive Tract Tumors on the Immune SystemLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationPhase II Trial of Allovectin-7® for Head and Neck CancerAllogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological MalignanciesRTA 402 in Advanced Solid Tumors or Lymphoid MalignanciesA Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological MalignancyBasiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused LymphopeniaPilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic MalignanciesCollecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerGene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural EffusionCD56+CD3- NK Cells Following Allogeneic Stem Cell TransplantationStudy of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy
P1050
P1423
P1542
P1889
Cancer of unknown primary originnon-Hodgkin lymphomanerve sheath neoplasmsAillsebone neoplasmtumorsoft tissue neoplasmmetastasiscentral nervous system primitive neuroectodermal neoplasmskin neoplasmhead neoplasmpapillary cystic tumoradipose tissue neoplasmVulvar tumorsbenign parathyroid gland neoplasmneoplasm in animalsthymus neoplasmcastration-resistant prostatic neoplasmglandular and epithelial neoplasmrare neoplastic diseasecystic neoplasmoral cavity neoplasmnervous system neoplasmneoplasm of jawaxillary neoplasmbladder neoplasmurinary system neoplasmfemale reproductive system neoplasmuterine cervix neoplasmuterine neoplasmesophageal neoplasmbreast neoplasmfallopian tube neoplasmgastrointestinal neoplasmlaryngeal neoplasmnasopharyngeal neoplasmgerm cell and embryonal neoplasmspituitary neoplasmrespiratory tract neoplasmcolorectal neoplasm
P279
description
abnormal mass of tissue as a result of abnormal growth or division of cells
@en
in patologia, massa di tessuto ...... che hanno indotto il processo
@it
masa anormal de tejido como resultado del crecimiento o division celular
@es
néoformation de tissus corpore ...... nt de la croissance cellulaire
@fr
tip de creștere anormală și excesivă (neoplazie) a unui țesut
@ro
μια ανώμαλη μάζα ιστού που είναι αποτέλεσμα ανώμαλου πολλαπλασιασμού των κυττάρων
@el
ненармальная маса тканак як вынік ненармальнага росту ці дзяленьня вузаў
@be-tarask
ненормальна маса тканин як результат аномального росту або поділу клітин
@uk
ненормальная масса тканей как результат аномального роста или деления клеток
@ru
كتلة غير طبيعية من الأنسجة نتيجة نمو أو انقسام غير طبيعي للخلايا
@ar
name
Khối u
@vi
Neoplasie
@de
Tiwmor
@cy
gewas
@af
kasvaja
@et
neoplasi
@da
neoplasi
@nb
neoplasi
@sv
neoplasia
@es
neoplasia
@eu
type
label
Khối u
@vi
Neoplasie
@de
Tiwmor
@cy
gewas
@af
kasvaja
@et
neoplasi
@da
neoplasi
@nb
neoplasi
@sv
neoplasia
@es
neoplasia
@eu
altLabel
Choroba nowotworowa
@pl
Choroby nowotworowe
@pl
Neoplasia
@ur
Neoplasm
@sv
Neoplasm
@ur
Neoplasma
@de
Nowotwory
@pl
affection néoplasique
@fr
cnoc ailse
@ga
doenças oncológicas
@pt
prefLabel
Khối u
@vi
Neoplasie
@de
Tiwmor
@cy
gewas
@af
kasvaja
@et
neoplasi
@da
neoplasi
@nb
neoplasi
@sv
neoplasia
@es
neoplasia
@eu
P6366
P2581
P486
P6680
P6694
P672
P1245
P1424
P1748
P1995
P2581
P279
P2888
P373
P3827
neoplastic-processes
P486
P6366
2779847749
2780635560
2908598618
2910512530